Evaluate Short-Term Outcomes of abciximab in ST-Segment Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials

OBJECTIVES: This meta-analysis was to verify the short-time efficacy and safety of abciximab in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI). BACKGROUND: Abciximab has long-term efficacy in patients with STEMI undergoing PCI, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Nan, Niu, Ying, Ma, Ying, Shang, Yao-Sheng, Zhong, Peng-Yu, Wang, Zhi-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168187/
https://www.ncbi.nlm.nih.gov/pubmed/35685429
http://dx.doi.org/10.1155/2022/3911414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168187/
https://www.ncbi.nlm.nih.gov/pubmed/35685429
http://dx.doi.org/10.1155/2022/3911414

Ejemplares similares